Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0002001011-25-000049
Filing Date
2025-07-02
Accepted
2025-07-02 19:03:42
Documents
1
Period of Report
2022-11-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 3/A  
1 PRIMARY DOCUMENT edgardoc.xml 3/A 2850
  Complete submission text file 0002001011-25-000049.txt   4364
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Issuer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O LIGAND PHARMACEUTICALS INC 3911 SORRENTO VALLEY BOULEVARD, STE 110 SAN DIEGO CA 92121
Business Address
Espinoza Octavio (Reporting) CIK: 0001905248 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-33093 | Film No.: 251103187